The inability to deliver therapeutic RNA molecules to cell types beyond the liver is holding back the progress of RNA medicine, but Sixfold Bioscience has a solution. The company has engineered ...

The mechanisms that underpin these connections between human endogenous retroviruses (HERVs) and disease are just beginning to emerge. Transcription of viral RNA can signal the presence of foreign DNA ...

including ensuring that the cell’s own RNA molecules don’t get destroyed by antiviral defenses on the lookout for foreign genetic material. Endogenous ADARs edit genetic material in the cell by ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...